Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr 7;9(7):e016509.
doi: 10.1161/JAHA.120.016509. Epub 2020 Apr 1.

Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?

Rami Sommerstein  1 , Michael M Kochen  2 , Franz H Messerli  3   4   5 , Christoph Gräni  3
Affiliations

Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?

Rami Sommerstein et al. J Am Heart Assoc. .
No abstract available

Keywords: ACE2; angiotensin II receptor blocker; angiotensin‐converting enzyme inhibitor; coronavirus disease 2019; epidemiology; infectious diseases.

PubMed Disclaimer

Comment in

References

    1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–733. - PMC - PubMed
    1. Dong E, Du H, Gardner L. An interactive web‐based dashboard to track COVID‐19 in real time. Lancet Infect Dis. 2020;pii: S1473‐3099(20)30120‐1 DOI: 10.1016/S1473-3099(20)30120-1. [Epub ahead of print]. - DOI - PMC - PubMed
    1. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team . The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID‐19)—China, 2020. China CDC Wkly. 2020;2:113–122. - PMC - PubMed
    1. Messerli FH, Bangalore S, Bavishi C, Rimoldi SF. Angiotensin‐converting enzyme inhibitors in hypertension: to use or not to use? J Am Coll Cardiol. 2018;71:1474–1482. - PubMed
    1. Hoffmann M, Kleine‐Weber H, Krüger N, Müller M, Drosten C, Pöhlmann S. The novel coronavirus 2019 (2019‐nCoV) uses the SARS‐coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. bioRxiv. 2020. 2020.01.31.929042. Posted January 31, 2020.

MeSH terms

Substances